TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07729137: Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Sponsor: Emmecell · Phase: PHASE2 · Area: RARE_ORPHAN · Target Enrollment: 121 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$13,802,000

Rescue Site Savings

+$9,115,500

Unlock Full NCT07729137 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07729137 Rescue Dossier →